Early research (Phase 1)Ended earlyNCT04320771
What this trial is testing
Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose of 10 mg Immediate Release Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight
Who this might be right for
Pharmacology, Clinical
Bayer 18